Hyperlipoproteinemia. 3. Drug therapy.
D000367:Age Factors; D002792:Cholestyramine Resin / Q000008:administration & dosage / Q000627:therapeutic use; D002914:Chylomicrons / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D004035:Diet Therapy; D004988:Ethers, Cyclic / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008074:Lipoproteins / Q000097:blood*; D009539:Nicotinic Acids / Q000627:therapeutic use; D011073:Polyamines / Q000627:therapeutic use; D011108:Polymers / Q000627:therapeutic use; D011372:Progestins / Q000627:therapeutic use; D013261:Sterols / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D002914:Chylomicrons; D004988:Ethers, Cyclic; D008074:Lipoproteins; D009539:Nicotinic Acids; D011073:Polyamines; D011108:Polymers; D011372:Progestins; D013261:Sterols; D014280:Triglycerides; D002792:Cholestyramine Resin; D002994:Clofibrate; D013974:Thyroxine